DCR:右侧结肠癌患者淋巴结转移的研究

2018-05-28 MedSci MedSci原创

背景及目的:右侧结肠癌患者的围术期淋巴结转移的报道很少,需要对其进一步探讨, 本项研究探讨肿瘤位置在右侧结肠癌患者围手术期淋巴结转移发生率及临床意义中的作用

背景及目的:右侧结肠癌患者的围术期淋巴结转移的报道很少,需要对其进一步探讨,
本项研究探讨肿瘤位置在右侧结肠癌患者围手术期淋巴结转移发生率及临床意义中的作用

方法:前瞻性分析2006年至2016年间在韩国某三级医院的右侧结肠癌患者。主要观察围手术期淋巴结转移的频率和肿瘤部位的作用以及围手术期淋巴结转移患者的临床特征。

结果:研究人员检查了752例右侧结肠癌患者,包括82例盲肠,554例升结肠和116例肝弯曲癌。20例患者(2.7%)有周围淋巴结转移。盲肠癌患者转移至围产期淋巴结的发生率为7.3%(6/82),升结肠癌患者为2.2%(12/554),肝癌患者为1.7%(2/116)挠曲癌症。三名患者有III期癌症,17名有IV期。所有3例周围淋巴结阳性和Ⅲ期癌患者均有盲肠肿瘤。相反,所有患有升结肠或肝曲癌和周围淋巴结阳性的患者都有IV期癌症。

结论:即使在右侧结肠癌中,周围回肠淋巴结转移也很少见,主要发生在IV期。然而,它发生在一些局部晚期盲肠癌患者。这些结果表明最佳切除末端回肠肠系膜可能具有临床益处,特别是在盲肠癌的治愈性手术中。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载须授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=320481, encodeId=61bd3204812b, content=结肠癌淋巴结转移的研究., beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Jun 01 07:27:01 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319848, encodeId=fedb319848a4, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed May 30 06:43:14 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293034, encodeId=187212930341d, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Wed May 30 05:45:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302515, encodeId=0949130251543, content=<a href='/topic/show?id=7be06602886' target=_blank style='color:#2F92EE;'>#淋巴结转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66028, encryptionId=7be06602886, topicName=淋巴结转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25e7304, createdName=snf701207, createdTime=Wed May 30 05:45:00 CST 2018, time=2018-05-30, status=1, ipAttribution=)]
    2018-06-01 jyzxjiangqin

    结肠癌淋巴结转移的研究.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=320481, encodeId=61bd3204812b, content=结肠癌淋巴结转移的研究., beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Jun 01 07:27:01 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319848, encodeId=fedb319848a4, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed May 30 06:43:14 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293034, encodeId=187212930341d, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Wed May 30 05:45:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302515, encodeId=0949130251543, content=<a href='/topic/show?id=7be06602886' target=_blank style='color:#2F92EE;'>#淋巴结转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66028, encryptionId=7be06602886, topicName=淋巴结转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25e7304, createdName=snf701207, createdTime=Wed May 30 05:45:00 CST 2018, time=2018-05-30, status=1, ipAttribution=)]
    2018-05-30 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=320481, encodeId=61bd3204812b, content=结肠癌淋巴结转移的研究., beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Jun 01 07:27:01 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319848, encodeId=fedb319848a4, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed May 30 06:43:14 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293034, encodeId=187212930341d, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Wed May 30 05:45:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302515, encodeId=0949130251543, content=<a href='/topic/show?id=7be06602886' target=_blank style='color:#2F92EE;'>#淋巴结转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66028, encryptionId=7be06602886, topicName=淋巴结转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25e7304, createdName=snf701207, createdTime=Wed May 30 05:45:00 CST 2018, time=2018-05-30, status=1, ipAttribution=)]
    2018-05-30 sodoo
  4. [GetPortalCommentsPageByObjectIdResponse(id=320481, encodeId=61bd3204812b, content=结肠癌淋巴结转移的研究., beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Jun 01 07:27:01 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319848, encodeId=fedb319848a4, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed May 30 06:43:14 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293034, encodeId=187212930341d, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Wed May 30 05:45:00 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302515, encodeId=0949130251543, content=<a href='/topic/show?id=7be06602886' target=_blank style='color:#2F92EE;'>#淋巴结转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66028, encryptionId=7be06602886, topicName=淋巴结转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25e7304, createdName=snf701207, createdTime=Wed May 30 05:45:00 CST 2018, time=2018-05-30, status=1, ipAttribution=)]

相关资讯

J Viral Hepat:直接抗病毒治疗,丙型肝炎病毒根除后,肝外淋巴结肿大消失

在直接抗病毒治疗后,先前肝脏外淋巴结肿大的患者,其中23.8%的患者,肝脏外淋巴结消失。需要更长的随访时间来阐明这一现象的临床重要性,特别是与HCC发生风险的相关性。

UROLOGY:非转移性高危肾细胞癌应用ASSURE (ECOG-ACRIN 2805)治疗方案

腹膜后淋巴结清除术已被证实对大部分恶性泌尿系统肿瘤都是有益的治疗手段,但其对治疗肾细胞癌是否有效尚不明确。该研究主要目的就是分析在肾癌根治术的基础上,腹膜后淋巴结清除术能否延长高危肾细胞癌患者的寿命。